Sort
39,280 grants matching “leukemia”
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
$1,545,130Russell E Ware · Cincinnati Childrens Hosp Med Ctr · U01 · FY2022 · HL
ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL
$1,544,922Thomas Jefferson University · P01 · FY2002 · CA
National Resource for Translational and Developmental Proteomics
$1,544,898Neil L Kelleher · Northwestern University · P41 · FY2015 · GM
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
$1,544,139Beth Israel Deaconess Medical Center · P01 · FY2003 · CA
Optimization of gene transfer and gene editing safety and efficacy focusing on the NHP model
$1,543,957Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Delaware/Christiana Care Community Clinical Oncology Program
$1,543,934Stephen S. Grubbs · Christiana Care Health Services, Inc. · U10 · FY2013 · CA
DELAWARE/CHRISTIANA CARE COMMUNITY CLINICAL ONCOLOGY PROGRAM
$1,543,934Stephen S. Grubbs · Christiana Care Health Services, Inc. · U10 · FY2013 · CA
Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma
$1,543,917James M Olson · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA
COG NCTN Network Group Operations Center
$1,543,656Peter C Adamson · Children'S Hosp Of Philadelphia · U10 · FY2014 · CA
Development of new antibody-based cancer therapies
$1,541,067Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Therapeutic Opportunities for Pediatric Astrocytoma
$1,540,004Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2014 · CA
Viral And Cellular Factors Governing Efficient Gene Delivery
$1,538,297Maribeth V. Eiden · National Institute Of Mental Health · ZIA · FY2010 · MH
A Novel Approach to Molecular Cell Pathologies of Human Down Syndrome and DS-AD
$1,537,729Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · HD
Genetic Analysis of T-cell Differentiation
$1,537,138Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Hazardous Substance Training for Emergency Responders
$1,536,437Patrick J Morrison · International Association Fire Fighters · T15 · FY2011 · OH
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,535,619Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
$1,535,611Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2025 · AI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
$1,535,611Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2022 · AI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
$1,535,611Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2023 · AI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
$1,535,611Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2024 · AI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
$1,535,096Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2021 · AI
Development of Gleevec for TB and TB/HIV
$1,534,659Daniel Kalman · Emory University · UH3 · FY2018 · AI
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
$1,534,395Beth Israel Deaconess Medical Center · P01 · FY2004 · CA
Cytokines and T Cell Development
$1,532,973Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
MOUSE MODELS FOR UNDERSTANDING HOST RESPONSES TO INTRACELLULAR PATHOGENS
$1,532,128Ellen A Robey · University Of California Berkeley · P01 · FY2007 · AI